Last reviewed · How we verify

NCT03392922

A Comparison the Intubation of a Left Sided Double Lumen Tube and Uniblocker

Completed NA Last updated 8 January 2019
What this trial tests

NA trial testing Uniblocker in Therapeutic Procedural Complication in 60 participants. Completed in 25 June 2018.

Timeline
6 January 2018
Primary endpoint
12 May 2018
25 June 2018

Quick facts

Lead sponsorThe First Hospital of Qinhuangdao
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingdouble
Primary purposeother
Enrollment60
Start date6 January 2018
Primary completion12 May 2018
Estimated completion25 June 2018
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The First Hospital of Qinhuangdao

Who can join

Adults 18 to 70, any sex, with Therapeutic Procedural Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One-lung ventilation (OLV) is required for the most thoracic surgery to facilitate surgical visualization by collapsing the lung. The double-lumen tube (DLT) and Uniblocker are the commonly used device for OLV.The objective of our study was to comparison the safety and effectiveness of the intubation of the Left-sided Double-lumen Tube and the Uniblocker under the guidence of chest computed tomography (CT) image.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The efficacy and adverse effects of the Uniblocker and left-side double-lumen tube for one-lung ventilation under the guidance of chest CT.
    Liu Z, Zhao L, Zhu Y, Bao L, et al · · 2020 · cited 9× · PMID 32256757 · DOI 10.3892/etm.2020.8492

Verify or expand the search:

Other The First Hospital of Qinhuangdao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03392922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing